Epidemiological Study of Autism Spectrum Disorders in Greece for 2021: Nationwide Prevalence in 2-17-Year-Old Children and Regional Disparities.
Raissa KouznetsovPanagiotis AngelopoulosSpyridon MoulinosIoannis DimakosPhilippos GourzisEleni JelastopuluPublished in: Journal of clinical medicine (2023)
This study estimated the crude prevalence of autism spectrum disorders (ASD) in Greece in 2021. A retrospective study was conducted for 2021 using data provided for research purposes for the first time by the Greek National Health Service Organization for Healthcare Services Provision (EOPYY) related to the ICD-10 diagnosis codes F84.0-F84.9 (ASD). Treatments were categorized by gender, age, and location. Statistical analysis was performed using the open-source software R. In total, 15,706 children aged 2-17 years were registered with ASD: 12,380 boys and 3326 girls. In total, 6,117,910 therapies were prescribed: 4,844,173 for boys and 1,273,737 for girls. Boys are estimated to be diagnosed 3.5 times more often than girls. On average, approximately 390 treatments are prescribed per person per year for both sexes. The annual prevalence is estimated at 0.94%, ranging from 0.42% to 1.44% depending on geographic region. Our findings provide evidence-based data for the planning of policies regarding health, education, and employment for people with ASD. The number of children and treatments makes ASD a public health concern to support children and their families and ensure equal participation in all aspects of society.
Keyphrases
- autism spectrum disorder
- public health
- healthcare
- intellectual disability
- attention deficit hyperactivity disorder
- young adults
- risk factors
- mental health
- electronic health record
- physical activity
- primary care
- quality improvement
- big data
- human health
- health information
- health insurance
- climate change
- affordable care act
- deep learning
- cross sectional
- artificial intelligence